Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trialAndrés Poveda, Nicolas Pécuchet, Anne Floquet et al.|The Lancet Oncology|2021Cited by 412
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)Richard D. Carvajal, Paul Nathan, Dana Ghiorghiu et al.|Journal of Clinical Oncology|2018Cited by 274
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint‐Ghislain, Manuel Rodrigues, Anne‐Céline Derrien et al.|European Journal of Cancer|2022Cited by 37
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafuspManuel Rodrigues, Shufang Renault, Toulsie Ramtohul et al.|Nature Communications|2024Cited by 30
Management of metastatic uveal melanoma: French expert consensus guidelinesManuel Rodrigues, Sophie Piperno‐Neumann, Vincent Servois et al.|Bulletin du Cancer|2025Cited by 3